{"id":21061,"date":"2024-03-01T13:45:40","date_gmt":"2024-03-01T18:45:40","guid":{"rendered":"https:\/\/oldals.thedev.ca\/health-canada-issues-a-notice-of-non-compliance-withdrawal-for-masitinib\/"},"modified":"2024-03-06T11:51:51","modified_gmt":"2024-03-06T16:51:51","slug":"sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib","status":"publish","type":"page","link":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/","title":{"rendered":"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 &#8211; Retrait pour le masitinib"},"content":{"rendered":"<p><strong>Le 1<sup>er<\/sup> mars 2024 \u2013<\/strong> AB Science a annonc\u00e9 l&#8217;\u00e9mission par Sant\u00e9 Canada d&#8217;un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) pour le masitinib dans la SLA en raison de probl\u00e8mes cliniques non r\u00e9solus et de probl\u00e8mes de fiabilit\u00e9 des donn\u00e9es.<\/p>\n<p>Un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) indique que la pr\u00e9sentation de m\u00e9dicament ne r\u00e9pond pas aux normes et exigences n\u00e9cessaires \u00e9tablies par Sant\u00e9 Canada, ce qui rend le processus d&#8217;examen incomplet et non conforme au moment de la d\u00e9livrance de l&#8217;avis.<\/p>\n<p>AB Science a la possibilit\u00e9 de soumettre une demande de r\u00e9vision dans un d\u00e9lai de 30 jours, au cours duquel Sant\u00e9 Canada r\u00e9examinerait la d\u00e9cision sur la base des donn\u00e9es suppl\u00e9mentaires fournies dans le but de s&#8217;assurer que masitinib r\u00e9pond aux normes r\u00e9glementaires n\u00e9cessaires pour les traitements de la SLA au Canada.<\/p>\n<p>Nous continuerons \u00e0 publier des mises \u00e0 jour d\u00e8s que nous en aurons connaissance. Pour en savoir plus, lisez le <a href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/02\/26\/2835372\/0\/fr\/AB-Science-annonce-que-Sant%C3%A9-Canada-a-%C3%A9mis-un-Avis-de-Non-Conformit%C3%A9-Retrait-ANC-R-pour-le-masitinib-dans-la-SLA.html\" target=\"_blank\" rel=\"noopener\">communiqu\u00e9 de presse<\/a> d&#8217;AB Science. Toute question sur le traitement peut \u00eatre adress\u00e9e \u00e0 l&#8217;\u00e9quipe de recherche de la Soci\u00e9t\u00e9 canadienne de la SLA \u00e0 l&#8217;adresse research@oldals.thedev.ca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le 1er mars 2024 \u2013 AB Science a annonc\u00e9 l&#8217;\u00e9mission par Sant\u00e9 Canada d&#8217;un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) pour le masitinib dans la SLA en raison de probl\u00e8mes cliniques non r\u00e9solus et de probl\u00e8mes de fiabilit\u00e9 des donn\u00e9es. Un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) indique que la pr\u00e9sentation de m\u00e9dicament ne r\u00e9pond [&hellip;]<\/p>\n","protected":false},"author":29,"featured_media":0,"parent":1569,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_stc_notifier_status":"","_stc_notifier_sent_time":"","_stc_notifier_request":false,"_stc_notifier_prevent":false,"_stc_subscriber_keywords":"","_stc_subscriber_search_areas":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada\" \/>\n<meta property=\"og:description\" content=\"Le 1er mars 2024 \u2013 AB Science a annonc\u00e9 l&#8217;\u00e9mission par Sant\u00e9 Canada d&#8217;un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) pour le masitinib dans la SLA en raison de probl\u00e8mes cliniques non r\u00e9solus et de probl\u00e8mes de fiabilit\u00e9 des donn\u00e9es. Un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) indique que la pr\u00e9sentation de m\u00e9dicament ne r\u00e9pond [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/\" \/>\n<meta property=\"og:site_name\" content=\"ALS Society of Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-06T16:51:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/\",\"url\":\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/\",\"name\":\"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada\",\"isPartOf\":{\"@id\":\"https:\/\/oldals.thedev.ca\/fr\/#website\"},\"datePublished\":\"2024-03-01T18:45:40+00:00\",\"dateModified\":\"2024-03-06T16:51:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/oldals.thedev.ca\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelles pour la communaut\u00e9 et m\u00e9dias\",\"item\":\"https:\/\/oldals.thedev.ca\/fr\/media-room\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 &#8211; Retrait pour le masitinib\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oldals.thedev.ca\/fr\/#website\",\"url\":\"https:\/\/oldals.thedev.ca\/fr\/\",\"name\":\"ALS Society of Canada\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oldals.thedev.ca\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada","og_description":"Le 1er mars 2024 \u2013 AB Science a annonc\u00e9 l&#8217;\u00e9mission par Sant\u00e9 Canada d&#8217;un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) pour le masitinib dans la SLA en raison de probl\u00e8mes cliniques non r\u00e9solus et de probl\u00e8mes de fiabilit\u00e9 des donn\u00e9es. Un Avis de Non-Conformit\u00e9 &#8211; Retrait (ANC-R) indique que la pr\u00e9sentation de m\u00e9dicament ne r\u00e9pond [&hellip;]","og_url":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/","og_site_name":"ALS Society of Canada","article_modified_time":"2024-03-06T16:51:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/","url":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/","name":"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 - Retrait pour le masitinib &#8211; ALS Society of Canada","isPartOf":{"@id":"https:\/\/oldals.thedev.ca\/fr\/#website"},"datePublished":"2024-03-01T18:45:40+00:00","dateModified":"2024-03-06T16:51:51+00:00","breadcrumb":{"@id":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/oldals.thedev.ca\/fr\/salle-de-presse\/sante-canada-emet-un-avis-de-non-conformite-retrait-pour-le-masitinib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/oldals.thedev.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvelles pour la communaut\u00e9 et m\u00e9dias","item":"https:\/\/oldals.thedev.ca\/fr\/media-room\/"},{"@type":"ListItem","position":3,"name":"Sant\u00e9 Canada \u00e9met un Avis de Non-Conformit\u00e9 &#8211; Retrait pour le masitinib"}]},{"@type":"WebSite","@id":"https:\/\/oldals.thedev.ca\/fr\/#website","url":"https:\/\/oldals.thedev.ca\/fr\/","name":"ALS Society of Canada","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oldals.thedev.ca\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/pages\/21061"}],"collection":[{"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/comments?post=21061"}],"version-history":[{"count":2,"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/pages\/21061\/revisions"}],"predecessor-version":[{"id":21063,"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/pages\/21061\/revisions\/21063"}],"up":[{"embeddable":true,"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/pages\/1569"}],"wp:attachment":[{"href":"https:\/\/oldals.thedev.ca\/fr\/wp-json\/wp\/v2\/media?parent=21061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}